ClinConnect ClinConnect Logo
Search / Trial NCT05868161

Pounce™ Thrombectomy System Retrospective Registry

Launched by SURMODICS, INC. · May 11, 2023

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

ClinConnect Summary

The Pounce™ Thrombectomy System Retrospective Registry is a clinical trial that is studying a new way to remove blood clots from the arteries in the legs, which is particularly important for patients with Peripheral Arterial Disease or Acute Limb Ischemia. This study is looking back at patients who have had a specific procedure using the Pounce Thrombectomy System to see how well it works and is being conducted at multiple centers across the United States.

To be eligible for the study, participants must be between the ages of 65 and 74 and have already undergone a procedure where the Pounce System was used. If you join the study, you’ll be asked to give your consent for researchers to collect information about your experience and outcomes after the treatment. It's important to note that this study is currently recruiting participants, and it’s open to both men and women. If you're considering participating, you’ll be contributing valuable information that could help improve treatments for blood clots in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Subject underwent an endovascular intervention where the Pounce Thrombectomy System was attempted
  • Subject is willing and able to provide informed consent prior to the collection of study data or a consent waiver is in place
  • Exclusion Criteria:
  • Subject is under the age of 18 years

About Surmodics, Inc.

Surmodics, Inc. is a leading provider of innovative drug delivery and in vitro diagnostic solutions, dedicated to enhancing patient care through advanced medical technologies. With a strong focus on developing proprietary products and platforms, Surmodics specializes in providing coatings for medical devices and drug delivery systems that improve efficacy and safety. The company aims to transform the treatment landscape in various therapeutic areas, including cardiovascular, ophthalmic, and vascular health, leveraging its extensive expertise in biomaterials and surface modifications. Committed to quality and compliance, Surmodics collaborates with partners in the medical device industry to bring cutting-edge solutions to market, ultimately improving patient outcomes.

Locations

Peoria, Illinois, United States

Munster, Indiana, United States

Cleveland, Ohio, United States

Nashville, Tennessee, United States

Minneapolis, Minnesota, United States

Sioux Falls, South Dakota, United States

Baton Rouge, Louisiana, United States

Greenville, South Carolina, United States

Austin, Texas, United States

Patients applied

0 patients applied

Trial Officials

Sean Lyden, MD

Principal Investigator

The Cleveland Clinic

Joseph Campbell, MD

Principal Investigator

OhioHealth

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported